Diadem SpA, a company developing the first blood-based test for the early prediction of progression to Alzheimer's disease (AD), presented clinical data at the...
Shanghai MicroPort MedBot (Group) Co., Ltd. announced that on November 22nd, 2022 MicroPort NaviBot International, LLC in recent collaboration with MicroPort Orthopedics has completed...
Oncolytics Biotech Inc. announced that the U.S. Food and Drug Administration (FDA) has granted Fast Track designation to pelareorep in combination with Roche's anti-PD-L1...
Biological Dynamics, a company developing its exosome-isolation ExoVerita platform for early disease diagnostics, announced it has received IRB approval and will soon begin to...
